Months Later, Drug Shortages Still a Problem
Months Later, Drug Shortages Still a ProblemWill healthcare manufacturing in Puerto Rico be back on its feet by next hurricane season?
How hospitals can cope with IV drug shortagesBecause of the impact of Hurricanes Maria and Irma on Puerto Rico’s infrastructure and drug manufacturing, hospitals face an ongoing shortage of IV fluids manufactured there.
Baxter Issues Recall of Nexterone Injection
Baxter Issues Recall of Nexterone InjectionThe affected lots could contain particulate matter.
Pharmacy Supply Lines Are Still Shaking After Storm Passes
Pharmacy Supply Lines Are Still Shaking After Storm PassesTwo hurricanes devastated the U.S. supply chain, affecting pharmacies all over—and leaving many to wonder what’s next.
FDA warns about dosing errors with antifungalAfter a death and a hospitalized patient, FDA is cautioning that differences in dosing regimens between the 2 oral formulations of Merck’s antifungal drug Noxafil (posaconazole) have resulted in dosing errors.
The 4 most problematic drug shortagesDrug shortages are significant public health threats. They can delay, or even deny, critical care for patients. Here are the four drugs in shortage that are among the most problematic.
FDA approves renal therapy solutionFDA approved Phoxillum Renal Replacement Solutions.
FDA drug approvals-January 2015FDA actions in brief, recommendations for approval, fast-track designations.
Compounding may not be best option during saline shortageThe shortage of saline solution among hospitals is ongoing and doesn’t appear to be resolving anytime soon, according to a quality executive with the American Society of Health-System Pharmacists (ASHP). In addition, safety concerns make it prohibitive for hospitals to compound their own solutions.
FDA approves Obizur for acquired hemophilia AFDA has approved Antihemophilic Factor (Recombinant), Porcine Sequence] (Obizur, Baxter) for the treatment of bleeding episodes in adults with acquired hemophilia A.